U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they ...

Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for ...

As the leader of Connecticut’s #insulin4all chapter, I’ve met countless patients who have struggled to afford their insulin.

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for ...

The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$ 11.17 billion by 2032, from US$ 7.36 billion in 2023. The market is mainly driven by growth rate of diabetes ...

A series of case reports to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), describe how a technology giving insulin doses ...

Antidiabetics Market is estimated to reach US$ 223 Billion, displaying a CAGR of 9.6% during the assessment period from 2022- ...

The global portable medical devices market is set for remarkable growth, with revenue expected to rise from USD 59.28 billion ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

The growing incidence of diabetes, driven by sedentary lifestyles and poor dietary habits, has heightened the need for insulin therapy to effectively control blood glucose levels. Additionally ...